Showing results (181-190 of 218) with videos related to
Sort By:
Pageof 22
Journal of the American Academy of Dermatology|February 21, 2016
Standardization of terminology in dermoscopy/dermatoscopy: Results of the third consensus conference of the International Society of DermoscopyHarald Kittler, Ashfaq A Marghoob, Giuseppe Argenziano, et al.EMBO Molecular Medicine|September 7, 2016
ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitorsGeoffrey Richard, Stéphane Dalle, Marie-Ambre Monet, et al.Dermatologic Clinics|October 1, 2013
A clinico-dermoscopic approach for skin cancer screening: recommendations involving a survey of the International Dermoscopy SocietyGiuseppe Argenziano, Jason Giacomel, Iris Zalaudek, et al.The Lancet. Oncology|June 9, 2017
Dabrafenib plus trametinib in patients with BRAF<sup>V600</sup>-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trialMichael A Davies, Philippe Saiag, Caroline Robert, et al.Scientific Reports|December 21, 2019
Ultrathin perpendicular magnetic anisotropy CoFeB free layers for highly efficient, high speed writing in spin-transfer-torque magnetic random access memoryJodi M Iwata-Harms, Guenole Jan, Santiago Serrano-Guisan, et al.Journal of the American Academy of Dermatology|September 25, 2017
Accuracy of dermatoscopy for the diagnosis of nonpigmented cancers of the skinChristoph Sinz, Philipp Tschandl, Cliff Rosendahl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2017
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced MelanomaMario Sznol, Pier Francesco Ferrucci, David Hogg, et al.The Lancet. Oncology|August 3, 2016
Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trialPaolo A Ascierto, Grant A McArthur, Brigitte Dréno, et al.JAMA Dermatology|November 29, 2018
Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural NetworksPhilipp Tschandl, Cliff Rosendahl, Bengu Nisa Akay, et al.The New England Journal of Medicine|June 7, 2011
Ipilimumab plus dacarbazine for previously untreated metastatic melanomaCaroline Robert, Luc Thomas, Igor Bondarenko, et al.Pageof 22